Inogen, Inc
INGN
Positions held
Your positionsINGN isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $157.64M | Enterprise value | $67.89M | Trailing P/E | — | Forward P/E | -37.13 |
| PEG | — | Price / book | 0.91 | Beta | 1.50 | Dividend yield | 0.00% |
| Revenue growth | 3.0% | Earnings growth | — | Gross margin | 44.5% | Operating margin | -5.1% |
| Profit margin | -6.9% | ROE | -13.1% | ROA | -5.8% | Debt / equity | 0.09 |
| Current ratio | 2.74 | Free cash flow | -$1.77M | Analyst recommendation | strong_buy | Mean target | $12.00 |
| 52w high | $9.13 | 52w low | $5.05 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $95.1M | $85.1M | $81.7M | $92.4M | $92.3M |
| Op margin | -5.4% | -11.0% | -11.4% | -7.7% | -6.6% |
| Net income | -$3.9M | -$8.3M | -$7.1M | -$5.3M | -$4.2M |
| Gross margin | 45.5% | 44.5% | 43.1% | 44.7% | 44.8% |
| Gross profit | $43.3M | $37.9M | $35.2M | $41.3M | $41.3M |
| Operating income | -$5.1M | -$9.3M | -$9.3M | -$7.1M | -$6.1M |
- Revenue +12% vs prior quarter ($95M vs $85M).
- Gross margin 45.5% (was 44.5% prior quarter).
- Operating margin expanded to -5.4%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $349M | $336M | $316M | $377M | — |
| Op margin | -8.7% | -12.7% | -24.2% | -8.8% | — |
| Net income | -$22.7M | -$35.9M | -$102M | -$83.8M | — |
| Gross margin | 44.2% | 46.1% | 40.1% | 40.7% | — |
| Gross profit | $154M | $155M | $127M | $154M | — |
| Operating income | -$30.2M | -$42.5M | -$76.5M | -$33.1M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-01 · Inogen sharpens business focus with $25m oxygen rental unit divestment
2026-09-30 · Inogen to Sell US Oxygen Rental Business to Rotech for Up to $25 Million
2026-09-30 · Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech
2026-09-28 · Is ResMed A Better Way Than Stryker To Own Medical Device Growth?
2026-08-21 · Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
2026-08-19 · Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?
2026-08-17 · Inogen (INGN) Cuts Guidance Even As Profitability Climbs
2026-08-14 · Inogen (INGN) Q2 2026 Earnings Call Transcript
2026-08-11 · Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists
2026-08-11 · Should Investors Buy Inogen as Low Valuation Meets Execution Risk?
2026-08-10 · Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut
2026-08-07 · Inogen, Inc. Q2 2026 Earnings Call Summary
Price (daily)
Full chart · RSI · MACD · patterns